EPT Disclosure

RNS Number:8665E
Morgan Stanley Securities Ld(EPT)
20 June 2006




                 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS

                      WITH RECOGNISED INTERMEDIARY STATUS

                      DEALING IN A CLIENT-SERVING CAPACITY

                      (Rule 38.5(a) of the Takeover Code)



1.         KEY INFORMATION


Name of exempt principal trader                Morgan Stanley Securities Limited
Company dealt in                               Cambridge Antibody Technology Group Plc


Class of relevant security to which the        Ordinary Shares
dealings being disclosed relate (Note 1)

Date of dealing                                19 June 2006






2.         DEALINGS (Note 2)



(a)        Purchases and sales




Total number of securities purchased   Highest price paid (Note 3) GBP       Lowest price paid (Note 3) GBP


2,000                                  13.11                                 13.09




Total number of securities sold        Highest price received (Note 3) GBP   Lowest price received (Note 3) GBP


913                                    13.11                                 13.11



b)         Derivatives transactions (other than options)


Product name,         Long/short (Note 4)       Number of securities (Note 5)        Price per unit (Note 3) GBP

e.g. CFD
CFD                   LONG                      2,000                                13.11
CFD                   SHORT                     913                                  13.10





3.         OTHER INFORMATION



Agreements, arrangements or understandings relating to options or derivatives




Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating
to the voting rights of any relevant securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is
referenced.  If none, this should be stated.











Date of disclosure                                                20 June 2006

Contact name                                                      Mandeep Bhandal


Telephone number                                                  020 7677 5468

Name of offeree/offeror with which connected                      Cambridge Antibody Technology Group Plc


Nature of connection (Note 6)                                     Advisor







Notes



The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

EMMILFVIRRIIFIR